Philadelphia Pharmaceuticals PLC reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was JOD 4.62 million compared to JOD 6.23 million a year ago. Net income was JOD 0.20435 million compared to JOD 0.471689 million a year ago. Basic earnings per share from continuing operations was JOD 0.027 compared to JOD 0.063 a year ago.